ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "JLC PHARM"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Summary
Министерство юстиции РКActivities
2ОКЭДКомплексное обслуживание жилых объектов
Secondary
- 52291Транспортно-экспедиционные услуги
Contacts
Change history
Financial statements
PremiumPublic contracts
Assets
Bank accounts
Leadership
1- БД
Болатбек Дария Болатбекқызы
Director
since 13.06.2021
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Risks
0/17Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Found in government registries against the company’s director or founders. They do not affect the company’s own reliability score.
- FounderБОЛАТБЕК ДАРИЯ БОЛАТБЕКҚЫЗЫListed in the register of dormant taxpayers
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "JLC PHARM" (BIN 210640018969) is an active legal entity in Алматы, registered in 2021 (5 years on the market). Primary activity — комплексное обслуживание жилых объектов. Automated screening found 1 risk indicator for "JLC PHARM". Director on record — Болатбек Дария Болатбекқызы. Data current as of September 4, 2026.
Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.